title: Potentiating effects of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyaceta mide (PEPA) on excitatory synaptic transmission in dentate granule cells.
abstract: A novel sulfonylamino compound, 4-[2-(phenylsulfonylamino)-ethylthio]-2,6-difluoro-phenoxyaceta mide (PEPA) has been shown to selectively potentiate glutamate-induced currents in Xenopus oocytes expressing recombinant AMPA receptor subunits, GluR1-GluR4, by attenuation of desensitization. Here, we examined the effects of PEPA on responses to excitatory amino acids as well as on excitatory synaptic transmission in dentate granule cells of rat hippocampal slices using the whole-cell patch clamp technique. PEPA at 100 microM produced a 3-4-fold increases in the peak amplitude of current responses to AMPA and glutamate applied iontophoretically in the dentate granule cells, whereas it showed no effect on NMDA-induced currents. Excitatory postsynaptic currents (EPSCs) evoked in these neurons by stimulation of the perforant path had fast and slow components mediated by AMPA and NMDA receptors, respectively. PEPA at concentrations between 10 and 100 microM potentiated only the AMPA component of the EPSC (AMPA EPSC) in a dose-dependent manner without affecting the NMDA component. Although the potentiating effect of PEPA on the amplitude of the AMPA EPSC was weaker than that on the AMPA-induced current, it clearly prolonged the duration of the EPSC. PEPA at 100 microM increased the peak amplitude of the AMPA EPSC by 17%, and increased the area enclosed by the AMPA EPSC by 72%.
authors.affiliation: Department of Neurology, Gunma University School of Medicine, Maebashi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nakagawa
authors.forename: M
authors.initials: M
authors.lastname: Iino
authors.forename: M
authors.initials: M
authors.lastname: Sekiguchi
authors.forename: K
authors.initials: K
authors.lastname: Wada
authors.forename: S
authors.initials: S
authors.lastname: Ozawa
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D016282:Aspartic Acid Endopeptidases / Q000494:pharmacology*; D001581:Benzothiadiazines / Q000494:pharmacology; D018891:Dentate Gyrus / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D018846:Excitatory Amino Acids / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000502:physiology*; D018697:Nootropic Agents / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013569:Synapses / Q000187:drug effects / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects* / Q000502:physiology*
chemical_list: D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D018846:Excitatory Amino Acids; D018697:Nootropic Agents; D011760:Pyrrolidinones; C036466:aniracetam; C022325:aspartic proteinase A; D016282:Aspartic Acid Endopeptidases; C004639:cyclothiazide